Omada Health (NASDAQ:OMDA) Now Covered by JPMorgan Chase & Co.

Investment analysts at JPMorgan Chase & Co. began coverage on shares of Omada Health (NASDAQ:OMDA – Get Free Report) in a research note issued on Tuesday, MarketBeat.com reports. The brokerage set an “overweight” rating and a $19.00 price target on the stock. JPMorgan Chase & Co.‘s target price would suggest a potential upside of 4.97% […]

Leave a Reply

Your email address will not be published.

Previous post Roth Capital Reiterates “Neutral” Rating for Hecla Mining (NYSE:HL)
Next post UBS Group Initiates Coverage on Summit Therapeutics (NASDAQ:SMMT)